Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and ...
From 2011 to 2022, a declining trend in the prevalence of CRN among US adults with asthma was observed. Approximately every one in six adults with asthma was non-adherent to medications due to cost.
GSK plc GSK announced that the FDA has accepted its regulatory filing, seeking the approval of a new indication for Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD) treatment for ...
Nitric oxide (iNO) is selective pulmonary vasodilation and is delivered to the patient via mechanical ventilation after dilution with an oxygen/air mixture nitric oxide delivery system. Nitric oxide ...
The role of combination therapy is explored for the treatment of COPD. December 14th 2022EP. 5: Implementing Inhaled Corticosteroids (ICS) into COPD Patient Treatment Regimen Inhaled ...
The injection dampens part of the immune system that can go into overdrive in flare-ups of both asthma and a lung condition called chronic obstructive pulmonary disease (COPD). Benralizumab is ...
Benralizumab is currently used to treat severe asthma but is not used to treat COPD or asthma attacks. A woman with asthma uses her inhaler. Inhalers can treat shortness of breath among people ...
Roughly one-third of the Department of Veterans Affairs' projected medical budget shortfall in 2025 is due to the costs of new medications, including weight-loss drugs like Wegovy and Zepbound ...
Asthma patients to be shown leaflets detailing climate impact of inhalers as NHS estimates they account for 3pc of their carbon footprint Doctors have been told to stop prescribing blue inhalers ...